1. Merck CEO Frazier says COVID vaccine hype a 'grave disservice' to the public — Why Inovio is the front runner in COVID vaccine development — Biogen and Eisai trial drug in asymptomatic Alzheimer's — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Thoughts on Nuplazid for DRP

Discussion in 'Acadia Pharmaceuticals' started by anonymous, Feb 28, 2020 at 5:38 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I may be interested in the LTC Sales Specialist position but my main reservation is around the controversy surrounding Nuplazid and the deaths in Parkinson's patients. Why would this perception change for DRP patients and would this make it a difficult sell? Thanks in advance for intelligent and candid replies from existing LTC reps.
     

  2. anonymous

    anonymous Guest

    The drug isn’t causing death. It’s a degenerative disease
     
  3. anonymous

    anonymous Guest

    Original poster- whatever information you have is wayyy incomplete. If you get an offer take it!
     
  4. anonymous

    anonymous Guest

    So what’s the salary like for these ltc jobs? Are they low balling to attract glorified PCP reps or will they pay for strong CNS exp?
     
  5. anonymous

    anonymous Guest

    It’s not wayyy incomplete dumb ass. Let’s do a trial against placebo and make up our own scale to make the data look good. Let’s be honest, the drug takes a while to kick in and at some point it wears off. Ask any psych and they will confirm this. Get off your high horse and pray you get bought out, which is why most of the people have stuck around. Waiting for a pay day $$$ which is what was promised 4 years ago.